Singapore markets close in 5 hours 39 minutes
Straits Times Index
3,247.62 -9.20 (-0.28%) Nikkei
28,861.76 -10.02 (-0.03%) Hang Seng
20,088.54 +47.68 (+0.24%) FTSE 100
7,509.15 +8.26 (+0.11%) BTC-USD
23,942.61 -1,192.98 (-4.75%) CMC Crypto 200
566.34 -24.42 (-4.13%)
GSK plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:48PM BST
| Previous close | 1,450.00 |
| Open | 1,456.20 |
| Bid | 1,410.60 x 0 |
| Ask | 1,411.20 x 0 |
| Day's range | 1,393.30 - 1,462.00 |
| 52-week range | 1,371.00 - 2,746.59 |
| Volume | |
| Avg. volume | 12,319,189 |
| Market cap | 57.187B |
| Beta (5Y monthly) | 0.18 |
| PE ratio (TTM) | 12.33 |
| EPS (TTM) | 1.14 |
| Earnings date | 02 Nov 2022 |
| Forward dividend & yield | 0.86 (5.95%) |
| Ex-dividend date | 18 Aug 2022 |
| 1y target est | N/A |
- Yahoo Finance Video
Pharma companies see sales slump amid ongoing Zantac litigation
Yahoo Finance health care reporter Anjalee Khemlani looks at which pharmaceutical stocks are being affected by litigation surrounding alleged carcinogenic materials in Zantac derivatives.
- Financial Times
GSK/Sanofi: Zantac tussle may be long and painful, precedents show
The legal battle will be rough. Damages, if awarded, could be as high as $45bn, according to Morgan Stanley. Shares in GSK, Haleon and Sanofi began to recover on Friday after the companies said their legal positions were strong.
- Yahoo Finance UK
FTSE 100: GSK loses £4.5bn in value on Zantac lawsuit concerns
The FTSE 100 pharmaceutical giant's share price suffered its biggest drop since 1998 on Thursday.
© 2022 Yahoo. All rights reserved.
